As of 2025-07-08, the Relative Valuation of Sana Biotechnology Inc (SANA) is (12.58) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.10 USD, the upside of Sana Biotechnology Inc based on Relative Valuation is -505.9%.
The range of the Relative Valuation is (12.43) - (17.50) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.4x - 18.9x | 13.8x |
| Forward P/E multiples | 12.8x - 20.9x | 13.4x |
| Fair Price | (12.43) - (17.50) | (12.58) |
| Upside | -501.1% - -664.6% | -505.9% |
| Date | P/E |
| 2025-07-03 | -3.45 |
| 2025-07-02 | -3.16 |
| 2025-07-01 | -3.06 |
| 2025-06-30 | -2.95 |
| 2025-06-27 | -3.04 |
| 2025-06-26 | -3.10 |
| 2025-06-25 | -3.13 |
| 2025-06-24 | -3.21 |
| 2025-06-23 | -2.81 |
| 2025-06-20 | -2.82 |
| 2025-06-18 | -2.98 |
| 2025-06-17 | -3.04 |
| 2025-06-16 | -2.72 |
| 2025-06-13 | -2.80 |
| 2025-06-12 | -2.75 |
| 2025-06-11 | -2.92 |
| 2025-06-10 | -3.15 |
| 2025-06-09 | -3.06 |
| 2025-06-06 | -3.07 |
| 2025-06-05 | -2.76 |
| 2025-06-04 | -2.51 |
| 2025-06-03 | -2.53 |
| 2025-06-02 | -2.38 |
| 2025-05-30 | -2.35 |
| 2025-05-29 | -2.45 |
| 2025-05-28 | -2.43 |
| 2025-05-27 | -2.16 |
| 2025-05-23 | -2.15 |
| 2025-05-22 | -2.16 |
| 2025-05-21 | -2.12 |
| 2025-05-20 | -2.26 |
| 2025-05-19 | -1.82 |
| 2025-05-16 | -1.89 |
| 2025-05-15 | -1.85 |
| 2025-05-14 | -1.92 |
| 2025-05-13 | -1.94 |
| 2025-05-12 | -2.16 |
| 2025-05-09 | -1.97 |
| 2025-05-08 | -1.96 |
| 2025-05-07 | -1.84 |
| 2025-05-06 | -1.85 |
| 2025-05-05 | -2.02 |
| 2025-05-02 | -2.04 |
| 2025-05-01 | -2.05 |
| 2025-04-30 | -2.05 |
| 2025-04-29 | -1.85 |
| 2025-04-28 | -1.90 |
| 2025-04-25 | -1.91 |
| 2025-04-24 | -1.91 |
| 2025-04-23 | -1.85 |